Understand the source comparison
Brain Fog Peptides 2026 Update: Comparison
Cerebrolysin Multi-peptide neurotrophic blend, BDNF/NGF receptor agonism 5–10ml IM once daily 2.5ml IM twice daily (AM + afternoon) Half-life data shows shortest peptide fractions clear by hour 6. Split dosing maintains steady-state receptor occupancy Fraction
No winner is assigned.
This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.
- Cerebrolysin
- Multi-peptide neurotrophic blend, BDNF/NGF receptor agonism
- 5–10ml IM once daily
- 2.5ml IM twice daily (AM + afternoon)
- Half-life data shows shortest peptide fractions clear by hour 6. Split dosing maintains steady-state receptor occupancy
- Fractionated dosing eliminates the cognitive trough period that plagued earlier protocols
- Dihexa
- HGF pathway amplification, dendritic spine proliferation
- 1–5mg SC 3–5x/week
- 0.25–0.5mg SC 2–3x/week, cycled 4 weeks on / 2 weeks off
- Doses above 2mg trigger inflammatory rebound due to excessive synaptic turnover
- Microdosing at 0.25–0.5mg delivers cognitive benefits without metabolic overload
- P21 (CNTF fragment)
- BDNF gene transcription upregulation
- 5mg SC standalone
- 5mg SC + 30–40g protein within 90 min post-injection
- BDNF synthesis requires leucine substrate. Transcription alone doesn't produce protein
- Amino acid co-administration turns inconsistent results into reliable cognitive enhancement